MétaCan
Menu
Back to cohort
Record W2980722039 · doi:10.1161/res.125.suppl_1.410

Abstract 410: A Novel Combination Therapy Using First Trimester Human Umbilical Cord-Derived Mesenchymal Stromal Cells and Endothelial Progenitor Cells Significantly Improves Angiogenesis and Cardiac Recovery Following Myocardial Infarction

2019· article· en· W2980722039 on OpenAlexaff
Farwah Iqbal, Alexander Johnston, Poonam Mander, Brandon A. Wyse, Jun Wu, Ren‐Ke Li, Péter Száraz, Clifford Librach

Bibliographic record

VenueCirculation Research · 2019
Typearticle
Languageen
FieldMedicine
TopicMesenchymal stem cell research
Canadian institutionsToronto General HospitalBrandon UniversityCReATe Fertility CentreUniversity of Toronto
Fundersnot available
KeywordsAngiogenesisMedicineProgenitor cellUmbilical cordParacrine signallingMesenchymal stem cellVasculogenesisMyocardial infarctionUmbilical veinStromal cellAndrologyEjection fractionInternal medicineCell therapyCardiologyStem cellPathologyImmunologyBiologyHeart failureCell biologyReceptor

Abstract

fetched live from OpenAlex

Introduction: Umbilical cord-derived MSC show pericyte-like characteristics and demonstrate significant angiogenic potential via paracrine and direct support to the vasculature. Endothelial progenitor cells (EPC) have the potential to initiate vascular structures while maintaining paracrine properties following ischemic injury. Hypothesis: A combination therapy of first trimester umbilical cord MSC (FTM HUCPVC) with rat EPC will promote significant angiogenesis, cardiomyocyte survival and lead to functional cardiac recovery in a rat model of MI. Methods: MI was induced by LAD ligation on 8-week-old Fox rnu rats. 1 week later, rats with notable decrease (<30%) in ejection fraction (EF) were randomly separated into 4 treatment groups (n=9) and received intramyocardial injection of: G1: Media; G2: FTM HUPVC (3х10 6 cells/rat); G3: EPC (2.2х10 6 cells/rat); G4: FTM HUCPVC - EPC combination (1:2, total cells 3х10 6 cells/rat). Endpoint analysis was at 5-days and 4-weeks after injection. Results: 5-days after injection, exclusively G4 animals showed significant cardiac recovery, improved EF and FS compared to G1 - G2 - G3 ( p <0.01). IHC analysis showed significantly less apoptosis (caspase-3), more protease activity and sarcomeric actin in combination groups G4 compared to G1-G2-G3 ( p <0.001). More FTM HUCPVC and EPC colocalized adjunct to small capillaries in G4 . Significant increase of human Angpt-2 was detected in G4 compared to G1-G2-G3 (p<0.0001). Analysis at 4-weeks post-injection showed significant improvements in end-systolic volume (128μl) and EF (43%) in G4 compared to G2 (160μl) (35%) G3 (180μl) (30%) respectively (B) . LV contractility (dpdt, tau) significantly improved in G4 compared to G1 , G2 , G3 (p<0.001). Significant reduction in scar tissue and increased LV myocardial mass was found in G4 and G2. IHC analysis showed significantly more and larger (9um) capillaries localized in LAD injured myocardium in G4 compared to G1-G2-G3 ( p <0.001). Significantly more sarcomeric actinin and connexin-43 was identified in G4 compared to G1-G2-G3 . Conclusions: Our results show the superior potential of FTM HUCPVC - EPC combination cell therapy for faster and greater cardiovascular repair and recovery compared to single-cell-type treatments for MI.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.741
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.081
GPT teacher head0.350
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueCirculation ResearchSame topicMesenchymal stem cell researchFrench-language works237,207